What is the treatment for digital gangrene in scleroderma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Digital Gangrene in Scleroderma

Digital gangrene in scleroderma requires immediate surgical consultation for amputation consideration while simultaneously initiating aggressive intravenous prostacyclin therapy (iloprost). 1

Immediate Management Priorities

Surgical Assessment

  • Gangrene presence is an absolute indication for surgical evaluation and likely amputation 1
  • Do not delay surgical consultation—this represents a medical emergency requiring prompt evaluation 1
  • Assess for underlying osteomyelitis, which occurs in 11% of scleroderma digital ulcer cases and necessitates surgical intervention 1
  • Surgery is reserved for threatened digits with gangrene, underlying calcinosis, or failure of medical therapy 2

Concurrent Intravenous Therapy

  • Initiate intravenous iloprost (prostacyclin analogue) immediately for severe digital ischemia with gangrene 1
  • Iloprost is administered as continuous infusion over 6 hours daily for 5 consecutive days, with dosing adjusted to individual tolerability within 0.5 to 2.0 ng/kg/min 3
  • This therapy has demonstrated efficacy in healing digital ulcers and reducing new ulcer formation 1
  • Common adverse effects include headache, flushing, palpitations/tachycardia, nausea, vomiting, dizziness, and hypotension 3

Systemic Pharmacologic Management

First-Line Oral Vasodilators

  • Add PDE5 inhibitors (sildenafil or tadalafil) to the regimen, as they show beneficial effects in improving and reducing digital ulcers 1
  • These agents improve healing of existing digital ulcers (strength of recommendation: A) 4
  • Continue or initiate dihydropyridine calcium channel blockers (nifedipine) as first-line therapy for underlying Raynaud's phenomenon 4

Prevention of Further Ulceration

  • Consider bosentan (endothelin receptor antagonist) for prevention of new digital ulcers, particularly in patients with multiple (≥4) digital ulcers 1, 4
  • Bosentan reduces new digital ulcer formation by 48% but does not improve healing of existing ulcers 4
  • This should be added after failure of calcium channel blockers and prostanoid therapy 4

Wound Care and Infection Management

Local Wound Management

  • Specialized wound care by trained nurses and physicians is required 1
  • Apply silver sulfadiazine topical ointment to ulcerated areas 5
  • Antibiotics should only be added when infection is clinically suspected—avoid prophylactic antibiotics 1

Critical Pitfall to Avoid

  • Do not use prophylactic antibiotics routinely; reserve antibiotics for clinically suspected infection only 1, 6

Procedural Interventions

Digital Sympathectomy

  • Consider palmar digital sympathectomy if medical management fails 1, 5
  • This procedure has evidence supporting both healing and prevention of digital ulcers 1
  • In one series, chronic digital ulcerations healed within 6 weeks after surgery, with 6 of 9 hands remaining ulcer-free at 26-64 month follow-up 5
  • Reserve this intervention for patients who fail 12 weeks of aggressive medical management 5

Treatment Algorithm Summary

  1. Immediate: Surgical consultation for amputation evaluation + IV iloprost 1
  2. Concurrent: PDE5 inhibitors + calcium channel blockers 1, 4
  3. Add if multiple ulcers: Bosentan for prevention 1, 4
  4. Local care: Specialized wound management + antibiotics only if infection suspected 1
  5. If medical failure: Digital sympathectomy 1, 5

Additional Supportive Measures

  • Cessation of all vasoconstrictive agents (beta-blockers, ergot alkaloids, bleomycin, clonidine) 7, 5
  • Smoking cessation and cold avoidance 7
  • Monitor blood pressure carefully when combining vasodilatory therapies due to additive hypotensive effects 6

References

Guideline

Management of Digital Tip Ulcers with Gangrene in Systemic Sclerosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of finger ulcers in scleroderma.

The Journal of hand surgery, 1995

Guideline

Combination Therapy for Systemic Sclerosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Raynaud's Phenomenon Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.